Gisbert, J. P., Donday, M. G., Riestra Menéndez, S., Benitez, J. M., Navarro-Llavat, M., Busquets, D., . . . Morales Alvarado, V. J. (2025). Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: A randomised placebo-controlled clinical trial of GETECCU.
Citación estilo ChicagoGisbert, Javier Pérez, María G. Donday, Sabino Riestra Menéndez, Jose Manuel Benitez, Mercè Navarro-Llavat, David Busquets, Katja Serra Nilsson, Alfredo J. Lucendo, y Víctor Jair Morales Alvarado. Withdrawal of Antitumour Necrosis Factor in Inflammatory Bowel Disease Patients in Remission: A Randomised Placebo-controlled Clinical Trial of GETECCU. 2025.
Cita MLAGisbert, Javier Pérez, et al. Withdrawal of Antitumour Necrosis Factor in Inflammatory Bowel Disease Patients in Remission: A Randomised Placebo-controlled Clinical Trial of GETECCU. 2025.